Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Prof. Paula Videira NOVA School of Science and Technology, Portugal1 Talk
Paula Videira is a Professor at NOVA School of Science and Technology/ Universidade NOVA de Lisboa (FCT-NOVA) and she obtained her PhD in Biotechnology by the Instituto Superior Técnico in Lisbon where she initiated her passion by Glycobiology. She is the principal investigator of the Glycoimmunology Group at UCIBIO research... read moreunit. Her research’s interests are on the mechanisms that govern glycan expression and immune recognition and their impact on human biology and disease. She is focused on the: i) aberrant sialylated short O-glycans in cancers and their implications for tumour immunity and progression; ii) sialylated glycans expressed by immunomodulatory molecules; and iii) Congenital Disorders of glycosylation (CDG). She is committed to translating research findings into innovative therapies and treatments, centered on patient needs.
Since 2012 she leads the CDG&Allies, a unique patient-centric network, that gathers professionals and patient associations to foster research and awareness on CDG. In 2019, she co-founded the spin-off CellmAbs, a biopharmaceutical dedicated immuno-oncology agent that target tumour associated glycans.